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S.1. General Procedures  
Melting points, determined on a Leica Galen III hot stage apparatus, are uncorrected. FTIR spectra were recorded 




C NMR spectra were acquired 
on a Bruker Advance DPX 300 Spectrometer at 300 and 75.5 MHz respectively using CDCl3 or DMSO-d6 as 
solvents and tetramethylsilane (TMS) as internal reference and assigned through DEPT135 experiments. Coupling 
constant values were given in Hertz (Hz). Fully decoupled 
13
C NMR spectra are reported. Chemical shifts were 
reported in δ (ppm, parts per million) units relative to the internal standard TMS (δ = 0.00 ppm) and the splitting 
patterns were described as follows: s (singlet), d (doublet), t (triplet), q (quartet) m (multiplet) and brs (broad 
singlet). Elemental analyses were performed by an EA1110 Analyzer Fisons Instruments (Milan, Italy) and were 
within 0.4% of theoretical values. Piridinium, p-toluenesulfonate (PPTS) was prepared according to known 
procedure.
18,19
 All the reagents and solvents were purchased from Aldrich. The solvents were dried and distilled 
according to standard procedures. Petroleum ether refers to the fraction with boiling point 40-60 °C. Silica gel is 
Merck Silica gel (0.040-0.063 mm).   
 
S.2.  Synthesis and characterization of compounds 7-11 
2.2.1 Ethyl (E,Z)-(2-hydroxyimino)-3-oxobutanoate (7): To a precooled (0-5 °C) stirred solution of 3-oxobutyric 
acid ethyl ester (6) (5.15 g, 0.040 mol) and acetic acid (5.30 g, 5 mL, 0.088 mol, 2.19 equiv.) a solution of sodium 
nitrite (3.04 g, 0.044 mol, 1.1 equiv.) in 5.8 mL of water was added dropwise.  
The initially yellow mixture was stirred for 1 hour at room temperature becoming soon orange and then 
hydrolyzed with water (25 mL). The acidic waters were extracted with ethyl acetate (3 x 20 mL) and the combined 
organic extracts were washed with water (2 x 15 mL) and with NaHCO3 sat. then dried on Na2SO4 for the night. 
After removing of the organic solvent under reduced pressure 7 was obtained (6.39 g, 0.040 mol).  




H NMR (300 MHz, CDCl3, ppm), (major 
compound): δ = 10.25 (brs, 1H, OH), 4.39 (q, J = 7.1 Hz, 2H, CH2), 2.42 (s, 3H, CH3), 1.35 (t, J = 7.1 Hz, 3H, 
CH3). 
13
C NMR (75.5 MHz, CDCl3, ppm), (mixture of E/Z isomers): δ = 197.90 (Z) and 194.44 (E) (C=O of 
ketone), 162.04 (E) and 160.94 (Z) (C=O of ester), 151.15 (E) and 149.87 (Z) (C=NOH), 62.79 (Z) and 62.57 (E) 
(CH2O), 30.30 (Z) and 25.33 (E) (CH3C=O), 14.09 (Z) and 13.99 (E) (CH3). IR (Neat, cm
–1
), (mixture of E/Z 
isomers): 3347 (OH), 1744 and 1728 (C=O of ester), 1699 and 1687 (C=O of ketone), 1627 (C=N of oxime). Anal. 
Cald. for C6H9NO4 (Mw 159.14): C, 45.28; H, 5.70; N, 8.80; Found: C, 44.95; H, 6.10; N, 9.02. 
2.2.2 Ethyl (E,Z)-(2-hydroxyimino)-(E,Z)-3-(4-trifluoromethoxyphenylimino)butanoate (8): To a stirred solution of 
7 (5.4 g, 0.034 mol) in dry toluene (35 mL), 4-trifluoromethoxyaniline (6.02 g, 0.034 mol, 4.6 mL, 1.00 equiv.) 
and PPTS
18,19
 (0.4272 g, 0.0017 mol, 0.05 equiv.) were added and the resulting suspension was heated at 75 ° C. 
Immediately a solution is obtained which was stirred for 7 hours at 75 ° C under reduced pressure removing the 
separated water with a Dean-Stark-Trap.  
The light brown solution, which when cooled already showed some crystals, was evaporated under reduced 
pressure and the crude product was obtained as light brown solid. It was crystallized with CHCl3/n-pentane 
obtaining 8 (8.6 g; 0.027 mmol).  




H NMR (300 MHz, DMSO-d6, 
ppm), (major compound at equilibrium): δ = 12.66 (s, 1H, OH), 7.31 and 6.92 (m, 4H, CH= of phenyl), 4.27 (q, J 
= 7.1 Hz, 2H, CH2), 2.02 (s, 3H, CH3), 1.25 (t, J = 7.1 Hz, 3H, CH3). 
13
C NMR (75.5 MHz, DMSO-d6, ppm): δ = 
163.01 (C=NPh), 162.78 (C=O), 152.85 (C=NOH), 148.21 (C-OCF3 of phenyl), 144.83 (C-N of phenyl), 121.82 
(CH= of phenyl), 120.97 (CH= of phenyl), 118.45 (CF3), 60.90 (CH2), 15.05 (CH3C=N), 13.97 (CH3CH2). IR 
(KBr, cm
–1
): 3407 (OH), 3108 and 3001 (phenyl), 1709 (C=O of ester), 1656 (C=N of imine), 1627 (C=NOH of 





2.2.3 2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazole-4-carboxylic acid ethyl ester (9): To the imines 
mixture 8 (10.8 g, 0.034 mol) dissolved in dry toluene (34 mL), triethylorthoacetate (19.3 g, 21.8 mL, 0.119 mol, 
3.5 equiv.), p-toluensulphonic acid (0.13 g, 0.68 mmol, 0.02 equiv.) and Pd/C 10% (0.800 g) were added.  
The suspension was stirred under H2 at 1.5 bar for 5 hours at r.t. At the end of the reaction, catalyst was filtered on 




 The yellow solution was extracted with 1 N HCl until transparent waters; then these acidic waters 
were neutralized with 2 N NaOH  (pH = 7), extracted with dichloromethane (4 x 25 mL) and dried on Na2SO4. 
After removal of the solvent under reduced pressure the crude product was obtained as a light brown solid which 
was treated with petroleum ether instead of n-eptane,
12
 to obtain 9 (7.84 g, 0.024 mmol). 
Procedure b. In another preparation from 8 (1.73 g, 5.44 mmol) the yellow solution was directly evaporated at 
reduced pressure obtaining a yellow oil which when cool crystallized. This crude product was treated with 
petroleum ether to obtain 9 (1.13 g, 3.44 mmol).  
Procedure a.
12











H NMR (300 MHz, CDCl3, ppm): δ = 7.38-7.25 (m, 4H, CH= of phenyl), 
4.37 (q, J = 7.1 Hz, 2H, CH2), 2.30 (s, 3H, CH3), 2.25 (s, 3H, CH3), 1.40 (t, J = 7.1 Hz, 3H, CH3). 
13
C NMR (75.5 
MHz, CDCl3, ppm): δ = 163.21 (C=O of ester), 149.92 (C-OCF3 of phenyl), 144.99, 136.76, 133.58 (C of  
imidazole), 129.21 (CH= of phenyl), 127.19 (C-N of phenyl), 122.33 (CH= of phenyl), 122.09 and 118.67 (CF3, 
1
JCF = 256 Hz), 60.56 (CH2O), 14.54 (CH3C), 13.65 (CH3C), 10.83 (CH3CH2). IR (KBr, cm
–1
): 3114 and 3059 
(aromatics), 1709 (C=O of ester). Anal. Cald. for C15H15N2O3F3 (Mw 328.29): C, 54.88; H, 4.61; N, 8.54; Found: 
C, 54.80; H, 4.62; N, 8.80. 
2.2.4 2-(2-Chloropyridin-4-yl)-1-[2,5-dimethyl-1-(4-trifluoromthoxyphenyl)- 1H-imidazol-4-yl]ethanone (10): To 
a precooled (0-5°C) solution of  0.5 M potassium bis(trimethylsilyl)amide (KHMDS) (10.5 g, 0.0483 mol, 2.1 
equiv.) in dry toluene (100 mL) a solution of 9 (7.57 g, 0.023 mol, 1 equiv.) and 2-chloro-4-methylpyridine (2.96 
g, 0.023 mol, 1.01 equiv.) in dry toluene (115 mL) were dripped. The orange suspension was stirred at 0-5°C for 1 
hour then added with 2.9 eq. of AcOH (3.99 g, 0.0665 mol, 3.8 mL) and  H2O (90 mL) and neutralized with acetic 
acid (q.b  at pH = 7). The aqueous phase was separated and the organic phase was washed with water (105 mL).  
The combined waters were extracted with ethyl acetate (140 mL) and the combined organic phases were dried over 
anhydrous MgSO4 overnight. After removal of the solvent under reduced pressure the crude product was obtained 
as a pale orange oil which crystallized on standing. The crystals so obtained were treated with n-pentane with 
stirring to get 10 (7.7 g, 0.019 mol).  






H NMR (300 MHz, CDCl3, 
ppm): δ = 8.31 (d, Jo = 5.0 Hz, 1H, CH= of pyridine), 7.44-7.24 [m, 6H, (4CH= of phenyl + 2CH= of pyridine)], 
4.35 (s, 2H, CH2), 2.32 (s, 3H, CH3), 2.26 (s, 3H, CH3). 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 192.49 (C=O of 
ketone), 151.51 (C-OCF3 of phenyl), 149.87 (C of pyridine), 149.35 (CH= of pyridine), 147.99 (C of pyridine), 
144.21 (C of imidazole), 137.01 (C of imidazole), 135.02 (C of phenyl), 133.57 (C of imidazole), 129.05 (CH= of 
phenyl), 125.73 (CH= of pyridine), 124.20 (CH= of pyridine), 122.34 (CH= of phenyl), 122.08 and 118.65 (CF3, 
1
JCF = 259 Hz), 44.72 (CH2), 13.87 (CH3), 11.16 (CH3). IR (KBr, cm
–1
): 3072 (aromatics), 1671 (C=O of ketone). 
Anal. Cald. for C19H15N3O2F3Cl (Mw 409.79): C, 55.68; H, 3.69; N, 10.26; Found: C, 55.67; H, 3.62; N, 10.57. 
2.2.5 3-Chloro-2-(2-chloropyridin-4-yl)-3-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-yl]propenal 
(11): 2-(2-Chloropyridin-4-yl)-1-[2,5-dimethyl-1-(4-trifluoromthoxyphenyl)-1H-imidazol-4-yl]ethanone (10) from 
the preceding step (7.9 g, 0.019 mol) was dissolved in dry dichloromethane (58 mL) and added dropwise to a 
precooled (0-5 °C) suspension of (chloromethylene)dimethyliminium chloride (6.2 g, 0.048 mol, 2.5 equiv.) in dry 
dichloromethane (35 mL). The reaction mixture was stirred at 0-5 °C for 1 hour, then diluted with water (100 mL).  
At reduced pressure ~110 mL of dichloromethane were removed obtaining a suspension which was filtered, the 
residue mass was washed with water and then dissolved in dry dichloromethane. The mixture 
H2O/dichloromethane (pH = 1) was neutralized with 4 N NaOH (15 mL). After separation of the organic phase, the 
aqueous layer was extracted with dry dichloromethane (q.b at colorless extracts) and the combined organic phases 
were washed with water. The organic solvent was dried on MgSO4 overnight then evaporated at reduced pressure 
to get crude 11 as an orange oil which crystallized on standing. It was treated with petroleum ether under stirring 











H NMR (300 
MHz, CDCl3, ppm): δ = 9.85 (brs, 1H, CH of aldehyde), 8.45 (d, Jo = 4.8 Hz, 1H, CH= of pyridine), 7.48-7.29 [m, 
6H, (4CH= of phenyl + 2 CH= of pyridine)], 2.30 (brs, 3H, CH3), 2.16 (s, 3H, CH3). 
13
C NMR (75.5 MHz, CDCl3, 
ppm): δ = 188.64 (C=O of aldehyde), 151.54 (C-OCF3 of phenyl), 150.13 (C of pyridine), 149.62 (CH= of 
pyridine), 148.99 (C of pyridine), 146.17 (C of imidazole), 145.21 (C of imidazole), 136.79 (C of phenyl), 133.60 
(C of imidazole), 131.54 (C=C), 129.38 (C=C), 129.14 (CH= of phenyl), 125.59-125.45 (CH= of pyridine), 
123.85-123.71 (CH= of pyridine) , 122.47 (CH= of phenyl), 122.06 and 118.63 (CF3, 
1
JCF = 259 Hz), 13.79 (CH3), 
11.23 (CH3). IR (KBr, cm
–1
): 3113, 3069,3038 and 3003 (aromatics), 1671 (C=O of aldehyde). Anal. Cald. for 
C20H14N3O2F3Cl2 (Mw 456.25): C, 52.65; H, 3.09; N, 7.01; Found: C, 52.86; H, 3.22; N, 7.35. 
2.3. Synthesis and characterization of 2-Chloro-4-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-
ylethynyl] pyridine (5): A solution of 3-Chloro-2-(2-chloropyridin-4-yl)-3-[2,5-dimethyl-1-(4-
trifluoromethoxyphenyl)-1H-imidazol-4-yl]propenal (11) (9.19 g, 0.020 mol) in dry tetrahydrofuran (110 mL) was 
added dropwise to a precooled (-10 to -15 °C) suspension of potassium tert-butoxide (4.9 g, 0.044 mol, 2.2 equiv.) 
in dry tetrahydrofuran (60 mL). The light brown reaction mixture was stirred at 0-5 °C for 1 hour, then quenched 
at 0-5 °C with 1 N HCl (100 mL). Volatiles were evaporated under reduced pressure (40 °C) and the suspension 
which arose was filtered. This compound, the HCl salt of 5, was washed with water (60 mL). This material was 
taken up in dichloromethane (q.b. to dissolve the mass) and treated with 1 N NaHCO3 solution (107 mL, pH = 7-
8).  
The aqueous layer was separated and extracted with dichloromethane until colorless extracts. The organic phases 
were washed with water (100 mL), dried on MgSO4 overnight and then evaporated at reduced pressure to get crude 
5 as a dark solid which was crystallized from  DCM/n-pentane obtaining 5 (4.95 g, 0.013 mol).  







NMR (300 MHz, DMSO-d6, ppm): δ = 8.42 (d, Jo = 5.1 Hz, 1H, CH= of pyridine), 7.67-7.50 [m, 5H, (4 CH= of 
phenyl + 1 CH= of pyridine)], 7.49 (d, Jm = 1.36 Hz 1H, CH= of pyridine), 2.34 (s, 3H, CH3), 2.16 (s, 3H, CH3), 
2.15 (s, 3H, CH3). 
13
C NMR (75.5 MHz, DMSO-d6, ppm): δ = 150.66 (C-OCF3 of phenyl), 150.02 (CH= of 
pyridine), 148.43 (C of pyridine), 144.86 (C-N of phenyl), 136.11 (C of imidazole), 134.31 (C of imidazole), 
134.10 (C of imidazole), 129.59 (CH= of phenyl), 124.59 (CH= of pyridine), 123.95 (CH= of pyridine), 122.24 
(CH= of phenyl), 121.66 and 118.25 (CF3, 
1
JCF  = 257 Hz), 117.92 (C of pyridine), 90.96 (C of alkine), 87.41 (C of 
alkine), 13.48 (CH3), 10.09 (CH3). IR (KBr, cm
–1
): 3060 (aromatics), 2211 (alkine). Anal. Cald. for 














































IR spectrum of 2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazole-4-carboxylic acid ethyl 









IR spectrum of 2-(2-Chloropyridin-4-yl)-1-[2,5-dimethyl-1-(4-trifluoromthoxyphenyl)-1H-imidazol-4-yl]ethanone 




IR spectrum of 3-Chloro-2-(2-chloropyridin-4-yl)-3-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-
















H NMR and 
13
C NMR spectra of compounds 7-11 and 5 (CTEP) 
 
1


























Abundance (%) of the different peaks in 
the various batches over time 
 #1 #2 






12.65 77.7 31.9 61.4 88.3 32.8 
12.79 0 0 3.3 0 3.0 
12.98 2.5 1.5 0 0 0 
13.01 11.1 2.6 32.0 8.4 30.7 
13.24 8.9 64.0 3.0 3.2 33.5 
 
1
H NMR (DMSO-d6) spectrum of 8 acquired at r.t. (peaks of the OH group): (a) batch #1 freshly prepared, (b) 
batch #1 after a week at r.t., (c, e) batch #2 freshly prepared, (d) batch #2 after a day at r.t., (f) batch #2 after 5 
months at r.t.. and related Table of abundance (%) 
 
1
H-NMR (DMSO-d6) spectrum of 8 [batch #2 after 5 months at r.t. (peaks of the OH group)]: (a) acquired at r.t., 
(b) acquired at 75°C (c) acquired at r.t. after heating up and then cooling (d) acquired at r.t after heating up at 75°C 





Abundance (%) of the different peaks in batch #2 











12.35 0 47.9 0 0 
12.67 32.8 0 49.1 18.2 
12.72 0 11.1 0 0 
12.79 3.0 0 0 0 
12.94 0 40.9 0 0 
12.98 0 0 3.0 5.2 
13.03 30.7 0 6.4 2.2 
13.26 33.5 0 41.5 74.3 






aafter heating up for few minutes at 75°C and then cooling; 










Abundance (%)  of the different peaks in the 
various batches over time and by heating 
 #1 #2 






12.65 77.7 31.9 32.8 49.1 
12.98 2.5 1.5 0 3.0 
13.01 11.1 2.6 30.7 6.4 
13.24 8.9 64.0 33.5 41.5 
 
1
H-NMR (DMSO-d6) spectrum of 8 acquired at r.t. (peaks of the OH group): (a) batch #1 freshly prepared, (b) 
batch #1 after a week at r.t., (c) batch #2 after 5 months at r.t., (d) batch #2 after briefly heating up at 75°C and 




C NMR and DEPT135 of Ethyl (E,Z)-(2-hydroxyimino)-(E,Z)-3-(4-trifluoromethoxyphenylimino)butanoate (8)
 























H NMR of 2-(2-Chloropyridin-4-yl)-1-[2,5-dimethyl-1-(4-trifluoromthoxyphenyl)-1H-imidazol-4-yl]ethanone 




C NMR and DEPT135 of 2-(2-Chloropyridin-4-yl)-1-[2,5-dimethyl-1-(4-trifluoromthoxyphenyl)-1H-imidazol-4-










H NMR of 3-Chloro-2-(2-chloropyridin-4-yl)-3-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-





C NMR and DEPT135 of 3-Chloro-2-(2-chloropyridin-4-yl)-3-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-


























































Comparison beteween NMR spectra of compounds 9, 10 and 11: F1. 
1
H NMR of 9 (a) and of 10 (b), (300 MHz, CDCl3); F2. 
1
H NMR of 10 (a) and of 11 (b), 
(300 MHz, CDCl3); F3. 
13







H NMR of 2-Chloro-4-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-ylethynyl]pyridine (5) 




C NMR and DEPT135 of 2-Chloro-4-[2,5-dimethyl-1-(4-trifluoromethoxyphenyl)-1H-imidazol-4-



























S5. Percentage variation of geometric isomers of 8 in varius batches over time and/or with heating 
up deducted from 
1
H NMR (300 MHz, DMSO-d6) spectra  
 
       Table S1. Percentages of geometric isomers of 8 in varius batches over time (spectra acquired at r.t.) 











Sample A 8.9 % 11.1 % 2.5 % 77.7 % 
  Sample A
a
 64.0 % 2.6 % 1.5 % 31.9 % 
Sample B 3.0 % 32.3 % 3.3 % 62.4 % 
  Sample B
b
 3.2 % 8.4 % 0.0 % 88.3 % 
Sample B
c
 33.5 % 30.7 % 3.0 % 32.8 % 
             
 
a
After a week at r.t.; 
b
after a day at r.t.; 
c
after five months at r.t. 
 
      Table S2. Percentages of geometric isomers of 8 with heating up (spectra acquired at r.t. and at 75°C) 
Terms of acquisition of 
1
H NMR 














r.t. 33.5 % 30.7 % 3.0 % 32.8 % 
75°C 40.9 % 11.1 % 47.9 % 
r.t.
b
 41.5 % 6.4 % 3.0 % 49.1 % 
  r.t. after long heating up
c
 74.3 % 2.2 % 5.3 % 18.2 % 
      a
Kept for five months at r.t.;
  b
after heating up at 75°C and then cooling; 
c
75°C for 24 h and then cooling.  
 
 
        Table S3. Percentages of geometric isomers of 8 in varius batches over time and with heating up  
        (spectra acquired at r.t.) 













 8.9% 11.1% 2.5% 77.7% 
Sample A
b
 64% 2.6% 1.5% 31.9% 
Sample B
c
 33.5% 30.7% 3.0% 32.8% 
Sample B
c,d
 41.5% 6.4% 3.0% 49.1% 
              a
Freshly prepared; 
b
after a week; 
c
after five mouths at r.t.; 
d





















S6. Chemical and physical properties of compounds 7-11 and 5 (CTEP) 
 
Table S4. Formulas, MW, physical state, melting point and elemental analysis results of the reported 
compounds 




















C - 0.33 
H + 0.4 















C - 0.02 
H + 0.1 
N - 0.15 
























C - 0.08 
H + 0.01 




C19H15ClF3N3O2 409.79 Yellowish 
solid 







C - 0.01 
H - 0.07 

















C + 0.21 
H + 0.13 
N + 0.34 
 












C + 0.15 
H + 0.05 
N + 0.26 
 
a




Obtained with Procedure b 
 
